<DOC>
	<DOCNO>NCT01612273</DOCNO>
	<brief_summary>To explore efficacy triflusal patient symptomatic peripheral microcirculation dysfunction . Triflusal salicylate compound approve several country antithrombotic agent additionally vasodilatory effect . The hypothesis explore improvement peripheral microcirculation triflusal .</brief_summary>
	<brief_title>The Effect Triflusal Peripheral Microcirculation Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Salicylates</mesh_term>
	<mesh_term>Triflusal</mesh_term>
	<criteria>Between 40 70 year age Diagnosed vasospastic syndrome nailfold capillaroscopy ( Fingertip subject carbon dioxide 15Â°C 60 second . People find bloodflow standstill least 12 one capillary define vasospasticity ) More seven point 10question interview provide Nagashima et al . Written inform consent Prior document diabetes Overt peripheral artery disease Pregnant nursing bleed tendency Any contraindication antiplatelet agent Thrombocytopenia ( platelet &lt; 100,000mm3 ) Chronic liver disease ( ALT &gt; 100 IU/L AST &gt; 100 IU/L ) renal dysfunction ( creatinine &gt; 4.0 mg/dl ) Patients stop take aspirin</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Vasospastic syndrome</keyword>
	<keyword>Vascular dysregulation</keyword>
</DOC>